Medical Research

Innovations in Clinical Research Award

Purpose

The Doris Duke Innovations in Clinical Research Award has provided funding for early-stage research projects in clinical investigation to foster innovations in clinical research that advance the prevention, diagnosis and treatment of human disease.

Rationale & Program History

The Medical Research Program created the Innovations in Clinical Research Award (ICRA) to promote collaborations and catalyze breakthroughs in targeted disease areas. We believe that the potential of scientific discoveries to spur field-changing advances increases when new multidisciplinary perspectives are brought into the problem-solving process.

Since 2000, 74 awards totaling approximately $24 million have supported innovative clinical research in cardiovascular disease, stroke, blood disorders, sickle cell disease and the development of diagnostics and therapeutic monitoring of AIDS in resource-poor countries.    

Award Details

Since 2009, the Innovations in Clinical Research Award has provided three-year grants of $486,000 each to investigators conducting clinical research that had the potential to accelerate innovative breakthroughs in sickle cell disease. Several of these projects are ongoing. View the 2009-2015 grantees here

The ICRA grants program is undergoing strategic review by staff to ensure that it best supports current and future grantees. New grants will not be offered in 2016 during this strategic review.

To receive announcements about future competitions for this and other programs, subscribe to our listserv here.